MX9200431A - Azapironas:el uso en el desorden de hiperactividad de la falta de atencion. - Google Patents

Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.

Info

Publication number
MX9200431A
MX9200431A MX9200431A MX9200431A MX9200431A MX 9200431 A MX9200431 A MX 9200431A MX 9200431 A MX9200431 A MX 9200431A MX 9200431 A MX9200431 A MX 9200431A MX 9200431 A MX9200431 A MX 9200431A
Authority
MX
Mexico
Prior art keywords
azapironas
lack
attention
hyperactivity disorder
hyperactivity
Prior art date
Application number
MX9200431A
Other languages
English (en)
Inventor
Leslie A Riblet
Gordon R Mckinney
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MX9200431A publication Critical patent/MX9200431A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9200431A 1991-01-31 1992-01-31 Azapironas:el uso en el desorden de hiperactividad de la falta de atencion. MX9200431A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64825291A 1991-01-31 1991-01-31

Publications (1)

Publication Number Publication Date
MX9200431A true MX9200431A (es) 1992-11-01

Family

ID=24600045

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200431A MX9200431A (es) 1991-01-31 1992-01-31 Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.

Country Status (5)

Country Link
EP (1) EP0497314A1 (es)
JP (1) JPH04327532A (es)
CA (1) CA2060064A1 (es)
IL (1) IL100784A0 (es)
MX (1) MX9200431A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5292766A (en) * 1992-03-25 1994-03-08 Eli Lilly And Company Method for improving primary memory and/or learning
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
EP2455075B1 (en) 2005-07-06 2018-06-20 Sunovion Pharmaceuticals Inc. Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
CN101421228B (zh) 2006-03-31 2014-05-21 塞普拉柯公司 手性酰胺和胺的制备
AU2007299726A1 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
US20080171750A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation Of Neurogenesis With Use of Modafinil
CN102573823B (zh) * 2009-05-13 2015-01-07 桑诺维恩药品公司 包含反式去甲舍曲林和血清素受体1a激动剂/拮抗剂的组合物及其用途
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders

Also Published As

Publication number Publication date
CA2060064A1 (en) 1992-08-01
IL100784A0 (en) 1992-09-06
JPH04327532A (ja) 1992-11-17
EP0497314A1 (en) 1992-08-05

Similar Documents

Publication Publication Date Title
FI894095A0 (fi) Vaermare foer anvaendning i mikrovaogsugnar.
FR2670139B1 (fr) Valve doseuse utilisable en position inversee.
MX9203326A (es) Tijeras de uso general.
BR9501774A (pt) Umidificador e garrafa de água para uso com o mesmo
MX9200431A (es) Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.
MX9207307A (es) Mejoras en sujecion de tuberia.
DE59201461D1 (de) Gummilager.
ITTO921020A1 (it) Sedia smontabile.
DE59200498D1 (de) Regulierbares Gummilager.
MX9200706A (es) Composicion y uso.
ES1020518Y (es) Avisador de uso domestico para personas con deficiencias auditivas.
ES1023573Y (es) Prenda de uso intimo con aposito higienico.
ES1009127Y (es) Tumbona, en particular para playa.
ES1019233Y (es) Soporte para hamacas.
KR950005466U (ko) 의자가 부착된 배낭
ES1024223Y (es) Unidad hermetica de uso personal.
BR9003881A (pt) Aerador para fluidos em geral
DE68902824D1 (de) Senkrecht einstellbar rollender sessel.
MX9204795A (es) 1-fenil-1-benzoilamino-5-aminopentanos substituidos su preparacion y uso.
ITGE920114A0 (it) Ombrellone, in particolare da spiaggia, o simili.
ES1026279Y (es) Soporte expositor de un solo uso para golosinas y similares.
ES1018240Y (es) Estructura de apoyo para el coy o hamaca de red.
FI910171A0 (fi) Vaermepump med hoeg temperaturskillnad.
IT8804220V0 (it) Leggio doppio uso abbreviato dopus.
KR930020893U (ko) 등받이에 장식구를 설치한 철재의자